EFFECTS OF NABUMETONE AND ITS ACTIVE METABOLITE, 6-METHOXY-2-NAPHTHYLACETIC ACID (6-MNA), ON THROMBOXANE BIOSYNTHESIS IN-VIVO AND IN-VITRO

被引：0
|
作者：
PATRIGNANI, P [1 ]
CIPOLLONE, F [1 ]
DISIPIO, M [1 ]
DIFEBBO, C [1 ]
PORRECA, E [1 ]
GANCI, A [1 ]
DELBIANCO, A [1 ]
CUCCURULLO, F [1 ]
PATRONO, C [1 ]
机构：
[1] UNIV CHIETI,G DANNUZIO SCH MED,DEPT MED PATHOPHYSIOL,I-66013 CHIETI,ITALY
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 1994年 / 111卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P76 / P76
页数：1
相关论文
共 35 条
  • [21] Photosensitizing properties of 6-methoxy-2-naphthylacetic acid, the major metabolite of the phototoxic non-steroidal anti-inflammatory and analgesic drug nabumetone
    Canudas, N
    Zamora, D
    Villamizar, JE
    Fuentes, J
    Castelli, C
    Taddei, A
    PHARMAZIE, 2005, 60 (08): : 604 - 608
  • [22] THE COMPARATIVE RENAL PROSTAGLANDIN (PG) EFFECT OF INDOMETHACIN (IN) AND 6-METHOXY-2-NAPHTHYL-ACETIC ACID (6MNA), THE ACTIVE METABOLITE OF NABUMETONE
    GERBER, JG
    SPANGLER, RS
    NIES, AS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (02) : 239 - 239
  • [23] In Vitro Characterization of the Cytochrome P450 Isoforms Involved in the Metabolism of 6-Methoxy-2-napthylacetic Acid, an Active Metabolite of the Prodrug Nabumetone
    Matsumoto, Kaori
    Nemoto, Eiichi
    Hasegawa, Tetsuya
    Akimoto, Masayuki
    Sugibayashi, Kenji
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2011, 34 (05) : 734 - 739
  • [24] CONCENTRATION OF 6-METHOXY-2-NAPHTHYLACETIC ACID IN PLASMA, SYNOVIAL-FLUID AND SURROUNDING TISSUES OF PATIENTS WITH RHEUMATOID-ARTHRITIS OR OSTEOARTHRITIS AFTER A 4-DAYS-TREATMENT WITH NABUMETONE (ARTHAXAN)
    MIEHLKE, RK
    SCHNEIDER, S
    SORGEL, F
    MUTH, P
    HENSCHKE, F
    FEDDER, M
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 1991, 50 (02): : 103 - 108
  • [25] Simplex optimization of the variables affecting the micelle-stabilized room temperature phosphorescence of 6-methoxy-2-naphthylacetic acid and its kinetic determination in human urine
    Pulgarin, JAM
    Molina, AA
    Pardo, MTA
    ANALYTICAL BIOCHEMISTRY, 2005, 339 (01) : 157 - 164
  • [26] EFFECTS OF 6,6'-DITHIODINICOTINIC ACID (CPDS) AND ITS METABOLITE 6-MERCAPTONICOTINIC ACID (6-MNA) ON MURINE AND HAMSTER FIBROBLASTS (3T3 AND BHK) AND MURINE METASTATIC MELANOMA-CELLS (F10)
    DANCONA, S
    GUIDETTI, G
    LAZZARINI, A
    MAGON, M
    BERTI, T
    MAGNOLFI, G
    TOFFOLI, G
    CARRARA, M
    LUCIANI, S
    CHEMIOTERAPIA, 1986, 5 (04): : 219 - 227
  • [27] Roles of CYP2C9 and its variants (CYP2C9*2 and CYP2C9*3) in the metabolism of 6-methoxy-2-napthylacetic acid, an active metabolite of the prodrug nabumetone
    Matsumoto, Kaori
    Hasegawa, Tetsuya
    Ohara, Kosuke
    Takei, Chihiro
    Akimoto, Masayuki
    JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2020, 50 (01) : 71 - 79
  • [28] Roles of CYP2C9 and its variants (CYP2C9*2 and CYP2C9*3) in the metabolism of 6-methoxy-2-napthylacetic acid, an active metabolite of the prodrug nabumetone
    Kaori Matsumoto
    Tetsuya Hasegawa
    Kosuke Ohara
    Chihiro Takei
    Masayuki Akimoto
    Journal of Pharmaceutical Investigation, 2020, 50 : 71 - 79
  • [29] EFFECTS OF CLOPIDOGREL AND CLARITHROMYCIN ON THE DISPOSITION OF SIBUTRAMINE AND ITS ACTIVE METABOLITE M1 AND M2 IN VIVO IN RELATION TO CYP2B6 GENETIC POLYMORPHISM.
    Pan, W.
    Bae, S. K.
    Shim, E. J.
    Park, S. E.
    Shon, J. H.
    Shin, J. G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S8 - S8
  • [30] EFFECTS OF CLOPIDOGREL AND CLARITHROMYCIN ON THE DISPOSITION OF SIBUTRAMINE AND ITS ACTIVE METABOLITE M1 AND M2 IN VIVO IN RELATION TO CYP2B6 GENETIC POLYMORPHISM.
    Pan, W.
    Bae, S. K.
    Shim, E. J.
    Park, S. E.
    Shon, J. H.
    Shin, J. G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S1 - S1
1234